New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Lorlatinib found to be safe and effective for patients with ALK-driven relapsed/refractory high-risk neuroblastoma

Lorlatinib found to be safe and effective for patients with ALK-driven relapsed/refractory high-risk neuroblastoma

byChildren's Hospital of PhiladelphiaEfficacy of lorlatinib in patients with MIBG avid relapsed or refractory ALK-driven neuroblastoma. Shown are waterfall plots summarizing the best percent
World medicine December 04,2023
Lorlatinib found to be safe and effective for patients with ALK-driven relapsed/refractory high-risk neuroblastoma

Lorlatinib found to be safe and effective for patients with ALK-driven relapsed/refractory high-risk neuroblastoma

byChildren's Hospital of PhiladelphiaEfficacy of lorlatinib in patients with MIBG avid relapsed or refractory ALK-driven neuroblastoma. Shown are waterfall plots summarizing the best percent
World medicine December 04,2023
A promising outlook: CAR T cell therapy improves patient quality of life

A promising outlook: CAR T cell therapy improves patient quality of life

byAmerican Society of HematologyCredit: CC0 Public DomainChimeric antigen receptor T-cell (CAR-T) therapy has transformed cancer treatment, yet relatively few studies have investigated the impac
World medicine December 04,2023
A promising outlook: CAR T cell therapy improves patient quality of life

A promising outlook: CAR T cell therapy improves patient quality of life

byAmerican Society of HematologyCredit: CC0 Public DomainChimeric antigen receptor T-cell (CAR-T) therapy has transformed cancer treatment, yet relatively few studies have investigated the impac
World medicine December 04,2023
Possible explanation for long-term effects in leukemia survivors discovered

Possible explanation for long-term effects in leukemia survivors discovered

byLinköping UniversityHematopoietic precursor cells: promyelocyte in the center, two metamyelocytes next to it and band cells from a bone marrow aspirate. Credit: Bobjgalindo/WikipediaContrary t
World medicine December 04,2023
Possible explanation for long-term effects in leukemia survivors discovered

Possible explanation for long-term effects in leukemia survivors discovered

byLinköping UniversityHematopoietic precursor cells: promyelocyte in the center, two metamyelocytes next to it and band cells from a bone marrow aspirate. Credit: Bobjgalindo/WikipediaContrary t
World medicine December 04,2023
Molecular Signaling: The Future of Hair Loss Treatment?

Molecular Signaling: The Future of Hair Loss Treatment?

 by Kevin RandsWe’ve probably gone as far as we can or should in reducing the DHT in the scalp to combat DHT. What new direction can we take in developing alternative med
Dermatology December 04,2023
Molecular Signaling: The Future of Hair Loss Treatment?

Molecular Signaling: The Future of Hair Loss Treatment?

 by Kevin RandsWe’ve probably gone as far as we can or should in reducing the DHT in the scalp to combat DHT. What new direction can we take in developing alternative med
Dermatology December 04,2023
Validation of a therapy that overcomes chemotherapy resistance in colon and rectal cancer

Validation of a therapy that overcomes chemotherapy resistance in colon and rectal cancer

by IMIM (Hospital del Mar Medical Research Institute)Graphical abstract. Credit:Journal of Medicinal Chemistry(2023). DOI: 10.1021/acs.jmedchem.2c01717A multidisciplinary team made up of d
World medicine December 04,2023
Validation of a therapy that overcomes chemotherapy resistance in colon and rectal cancer

Validation of a therapy that overcomes chemotherapy resistance in colon and rectal cancer

by IMIM (Hospital del Mar Medical Research Institute)Graphical abstract. Credit:Journal of Medicinal Chemistry(2023). DOI: 10.1021/acs.jmedchem.2c01717A multidisciplinary team made up of d
World medicine December 04,2023
New technology illuminates bladder cancer detection

New technology illuminates bladder cancer detection

by Annie Pierce,University of California - San DiegoUC San Diego Health’s Aditya Bagrodia, MD, performs a flexible blue light cystoscopy procedure. Credit: University of California - San DiegoUC
World medicine December 04,2023
New technology illuminates bladder cancer detection

New technology illuminates bladder cancer detection

by Annie Pierce,University of California - San DiegoUC San Diego Health’s Aditya Bagrodia, MD, performs a flexible blue light cystoscopy procedure. Credit: University of California - San DiegoUC
World medicine December 04,2023
New Hair Loss Gene Identified

New Hair Loss Gene Identified

 by Kevin RandsResearchers at Columbia University are uncovering the mechanisms of previously unknown genes governing hair growth and cycling. In their latest findings, to be published this Friday, th
World medicine December 04,2023
New Hair Loss Gene Identified

New Hair Loss Gene Identified

 by Kevin RandsResearchers at Columbia University are uncovering the mechanisms of previously unknown genes governing hair growth and cycling. In their latest findings, to be published this Friday, th
World medicine December 04,2023
Risk for melanoma reduced for individuals with atopy

Risk for melanoma reduced for individuals with atopy

by Elana GotkineAtopy is associated with a reduction in the risk for melanoma, according to a study published online Feb. 28 inMelanoma Research.Jenni Komulainen, M.D., from the University of Ea
World medicine December 04,2023
Risk for melanoma reduced for individuals with atopy

Risk for melanoma reduced for individuals with atopy

by Elana GotkineAtopy is associated with a reduction in the risk for melanoma, according to a study published online Feb. 28 inMelanoma Research.Jenni Komulainen, M.D., from the University of Ea
World medicine December 04,2023
The impact of cortactin in cancer progression

The impact of cortactin in cancer progression

by Impact Journals LLCThe molecular mechanism(s) of how Wnt5a signaling could (i) induce ROR1 and cortactin association, tyrosine phosphorylation of cortactin, and activation of RhoA, (ii) enhance F-a
World medicine December 04,2023
The impact of cortactin in cancer progression

The impact of cortactin in cancer progression

by Impact Journals LLCThe molecular mechanism(s) of how Wnt5a signaling could (i) induce ROR1 and cortactin association, tyrosine phosphorylation of cortactin, and activation of RhoA, (ii) enhance F-a
World medicine December 04,2023
CPEB4 protein is essential for maintaining the antitumor function of T lymphocytes, reveals study

CPEB4 protein is essential for maintaining the antitumor function of T lymphocytes, reveals study

byInstitute for Research in Biomedicine (IRB Barcelona)Credit:The EMBO Journal(2023). DOI: 10.15252/embj.2022111494T lymphocytes are components of the immune system that are located
World medicine December 04,2023
CPEB4 protein is essential for maintaining the antitumor function of T lymphocytes, reveals study

CPEB4 protein is essential for maintaining the antitumor function of T lymphocytes, reveals study

byInstitute for Research in Biomedicine (IRB Barcelona)Credit:The EMBO Journal(2023). DOI: 10.15252/embj.2022111494T lymphocytes are components of the immune system that are located
World medicine December 04,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com